Found 56 matching trials
Defining the Ablative Dose for Y-90 TARE PHASE2 This study is being done to help doctors improve how they treat liver tumor...
Show More Location
Northwestern University
Learn More & Join Trial
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort NA OPERANDI project aims to address unmet clinical needs in the current manage...
Show More Location
Service de Médecine Nucléaire, Hôpital Beaujon
Learn More & Join Trial
Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization N/A Hepatocellular carcinoma (HCC) is one of the most common malignancies world...
Show More Location
University Hospital Zurich
Learn More & Join Trial
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases PHASE2 This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Show More Location
University of California, San Francisco
Learn More & Join Trial
A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE) NA This is a prospective, single-arm Phase II study designed to evaluate the s...
Show More Location
Yonsei University Health System, Severance Hospital
Learn More & Join Trial
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation N/A The purpose of this study is to study the way radioembolization works by co...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery PHASE2 RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow t...
Show More Location
Northwestern University, Northwestern Memorial Hospital
Learn More & Join Trial
Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma PHASE2 The purposed of this research is to study the safety and clinical activity ...
Show More Location
Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Response of Hepatic Tumors to Radioembolization PHASE2 The study enrolls patients with non-resectable or borderline resectable hep...
Show More Location
University Hospital Zurich, Divisions of Visceral Surgery and Nucelar Medicine
Learn More & Join Trial
Radioembolization Versus External Radiation Therapy PHASE2 The proposed study is a single site, prospective, randomized phase 2 study ...
Show More Location
Henry Ford Health System
Learn More & Join Trial